Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 2
1971 2
1972 1
1982 1
1986 3
1987 4
1988 3
1989 3
1990 4
1991 1
1992 4
1993 3
1994 3
1995 3
1996 4
1997 4
1998 3
1999 5
2000 2
2001 6
2002 4
2003 16
2004 15
2005 21
2006 10
2007 13
2008 7
2009 17
2010 13
2011 15
2012 16
2013 18
2014 4
2015 11
2016 22
2017 16
2018 10
2019 20
2020 23
2021 53
2022 45
2023 65
2024 77
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

491 results

Results by year

Filters applied: . Clear all
Page 1
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.
Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, González-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS; HELIOS-B Trial Investigators. Fontana M, et al. N Engl J Med. 2024 Aug 30. doi: 10.1056/NEJMoa2409134. Online ahead of print. N Engl J Med. 2024. PMID: 39213194
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Russo D, Schmitt M, Pilorge S, Stelljes M, Kawakita T, Teal VL, Haber B, Bopp C, Dadwal SS, Badshah C. Russo D, et al. Among authors: kawakita t. Lancet Haematol. 2024 Feb;11(2):e127-e135. doi: 10.1016/S2352-3026(23)00344-7. Epub 2023 Dec 21. Lancet Haematol. 2024. PMID: 38142695 Clinical Trial.
In Reply.
Onishi K, Huang JC, Kawakita T. Onishi K, et al. Among authors: kawakita t. Obstet Gynecol. 2024 May 1;143(5):e142-e143. doi: 10.1097/AOG.0000000000005561. Obstet Gynecol. 2024. PMID: 38636091 No abstract available.
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Estiú MC, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, Kebapcilar AG, Kebapcilar L, Kondrackienė J, Koster MPH, Kowalska-Kańka A, Kupčinskas L, Lee RH, Locatelli A, Macias RIR, Marschall HU, Oudijk MA, Raz Y, Rimon E, Shan D, Shao Y, Tribe R, Tripodi V, Yayla Abide C, Yenidede I, Thornton JG, Chappell LC, Williamson C. Ovadia C, et al. Among authors: kawakita t. Lancet. 2019 Mar 2;393(10174):899-909. doi: 10.1016/S0140-6736(18)31877-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30773280 Free PMC article.
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia.
Usuki K, Miyamoto T, Yamauchi T, Ando K, Ogawa Y, Onozawa M, Yamauchi T, Kiyoi H, Yokota A, Ikezoe T, Katsuoka Y, Takada S, Aotsuka N, Morita Y, Ishikawa T, Asada N, Ota S, Dohi A, Morimoto K, Imai S, Kishimoto U, Akashi K, Miyazaki Y; Study Group for NS-87/CPX-351. Usuki K, et al. Int J Hematol. 2024 Jun;119(6):647-659. doi: 10.1007/s12185-024-03733-z. Epub 2024 Mar 26. Int J Hematol. 2024. PMID: 38532078 Free PMC article. Clinical Trial.
In Reply.
Kawakita T, Grantz KL, Reddy UM, Sciscione AC. Kawakita T, et al. Obstet Gynecol. 2016 Nov;128(5):1183. doi: 10.1097/AOG.0000000000001730. Obstet Gynecol. 2016. PMID: 27776061 No abstract available.
Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.
Fuji S, Sugita J, Najima Y, Konishi T, Tanaka T, Ohigashi H, Eto T, Nagafuji K, Hiramoto N, Matsuoka KI, Maruyama Y, Ota S, Ishikawa J, Kawakita T, Akasaka T, Kamimura T, Hino M, Fukuda T, Atsuta Y, Yakushijin K. Fuji S, et al. Among authors: kawakita t. Br J Haematol. 2024 Mar;204(3):959-966. doi: 10.1111/bjh.19228. Epub 2023 Nov 30. Br J Haematol. 2024. PMID: 38037468
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission.
Yanada M, Yamasaki S, Kondo T, Kawata T, Harada K, Uchida N, Doki N, Yoshihara S, Katayama Y, Eto T, Tanaka M, Takada S, Kawakita T, Nishida T, Ota S, Serizawa K, Onizuka M, Kanda Y, Fukuda T, Atsuta Y, Konuma T. Yanada M, et al. Among authors: kawakita t. Leukemia. 2024 Mar;38(3):513-520. doi: 10.1038/s41375-023-02119-0. Epub 2023 Dec 21. Leukemia. 2024. PMID: 38129514
Neuroendocrine mechanisms of reproductive dysfunctions in undernourished condition.
Iwasa T, Yamamoto Y, Noguchi H, Takeda A, Minato S, Kamada S, Imaizumi J, Kagawa T, Yoshida A, Kawakita T, Yoshida K. Iwasa T, et al. Among authors: kawakita t. J Obstet Gynaecol Res. 2022 Mar;48(3):568-575. doi: 10.1111/jog.15144. Epub 2022 Jan 3. J Obstet Gynaecol Res. 2022. PMID: 34979587 Review.
491 results